GIURISATO, EMANUELE
 Distribuzione geografica
Continente #
NA - Nord America 3.230
EU - Europa 2.589
AS - Asia 1.495
SA - Sud America 243
AF - Africa 70
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.634
Nazione #
US - Stati Uniti d'America 3.197
IT - Italia 656
GB - Regno Unito 532
CN - Cina 499
SG - Singapore 445
RU - Federazione Russa 402
IE - Irlanda 281
BR - Brasile 204
UA - Ucraina 170
VN - Vietnam 146
SE - Svezia 142
FR - Francia 133
DE - Germania 124
HK - Hong Kong 116
KR - Corea 101
FI - Finlandia 63
IN - India 63
NL - Olanda 29
BD - Bangladesh 26
TR - Turchia 21
ZA - Sudafrica 20
CA - Canada 18
AR - Argentina 15
IQ - Iraq 13
KE - Kenya 13
NG - Nigeria 13
AT - Austria 12
BE - Belgio 12
JP - Giappone 12
MX - Messico 9
CO - Colombia 8
ID - Indonesia 8
SA - Arabia Saudita 8
EG - Egitto 7
PK - Pakistan 7
PL - Polonia 6
CI - Costa d'Avorio 5
ES - Italia 5
AE - Emirati Arabi Uniti 4
EC - Ecuador 4
RO - Romania 4
UZ - Uzbekistan 4
VE - Venezuela 4
CL - Cile 3
JO - Giordania 3
KZ - Kazakistan 3
MA - Marocco 3
AO - Angola 2
AU - Australia 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
ET - Etiopia 2
EU - Europa 2
GR - Grecia 2
MM - Myanmar 2
MY - Malesia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PE - Perù 2
PT - Portogallo 2
RS - Serbia 2
TN - Tunisia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
NI - Nicaragua 1
NP - Nepal 1
PR - Porto Rico 1
PY - Paraguay 1
QA - Qatar 1
RE - Reunion 1
SV - El Salvador 1
TW - Taiwan 1
Totale 7.634
Città #
Fairfield 392
Southend 391
Dublin 277
Singapore 263
Dallas 260
Ashburn 234
Siena 209
Woodbridge 187
San Jose 152
Santa Clara 143
Seattle 141
Houston 140
Jacksonville 134
Wilmington 134
Chandler 130
Cambridge 127
Ann Arbor 112
Hefei 112
Beijing 109
Hong Kong 106
Moscow 93
Seoul 84
Princeton 74
Milan 66
The Dalles 64
Council Bluffs 55
Florence 51
Nanjing 46
Ho Chi Minh City 42
Dong Ket 37
Lauterbourg 36
Los Angeles 36
London 32
New York 32
Munich 30
San Diego 28
San Mateo 27
Hanoi 26
Bengaluru 25
Buffalo 25
Helsinki 25
São Paulo 23
Boardman 18
Rome 18
Shanghai 16
Izmir 15
Brentford 14
Redondo Beach 14
Abuja 13
Chicago 13
Johannesburg 13
Nanchang 13
Atlanta 12
Brussels 12
Chennai 11
Orem 11
Changsha 10
Columbus 10
Menlo Park 10
Frankfurt am Main 9
Hebei 9
Shenyang 9
Amsterdam 8
Kunming 8
Lappeenranta 8
Nuremberg 8
Redwood City 8
San Francisco 8
Stockholm 8
Tokyo 8
Toronto 8
Brooklyn 7
Fremont 7
Haikou 7
Manchester 7
Zhengzhou 7
Casoria 6
Dearborn 6
Denver 6
Haiphong 6
Jinan 6
Rosà 6
Turku 6
Vienna 6
Abidjan 5
Brescia 5
Dhaka 5
Modena 5
Phoenix 5
Tianjin 5
Baghdad 4
Bari 4
Belo Horizonte 4
Biên Hòa 4
Bologna 4
Boston 4
Campi Bisenzio 4
Castelfiorentino 4
Chiusi 4
Contagem 4
Totale 5.185
Nome #
Vomocytosis of live pathogens from macrophages is regulated by the atypical MAP kinase ERK5 319
Myeloid ERK5 deficiency suppresses tumor growth by blocking protumor macrophage polarization via STAT3 inhibition 305
Defective spermatogenesis and testosterone levels in kinase suppressor of Ras1 (KSR1)-deficient mice 290
T cell receptor can be recruited to a subset of plasma membrane rafts, independently of cell signaling and attendantly to raft clustering 270
An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition 266
Diacylglycerol activates the influx of extracellular cations in T-lymphocytes independently of intracellular calcium-store depletion and possibly involving endogenous TRP6 gene products 259
Ultrastructural study of spermatogenesis in KSR2 deficient mice 233
The KSR2-calcineurin complex regulates STIM1-ORAI1 dynamics and Store-Operated Calcium Entry (SOCE) 233
Hyper-Activation of STAT3 Sustains Progression of Non-Papillary Basal-Type Bladder Cancer via FOSL1 Regulome 233
NRF2 activation by cysteine as a survival mechanism for triple-negative breast cancer cells 232
CSF-1R in Cancer: More than a Myeloid Cell Receptor 208
The stimulatory potency of T cell antigens is influenced by the formation of the immunological synapse 207
Macrophage-secreted myogenic factors: a promising tool for greatly enhancing the proliferative capacity of myoblasts in vitro and in vivo 203
Discovery of a gatekeeper residue in the C terminal tail of the extracellular signal-regulated protein kinase 5 (ERK5) 202
KSR1 modulates the sensitivity of the Mitogen-Activated Protein Kinase pathway activation in T cells without altering fundamental system outputs. 192
Can tumor cells proliferate without ERK5? 191
The extracellular regulated protein kinase 5 (ERK5) is a key regulator of macrophage activation in tumour 188
The Mitogen-Activated Protein Kinase Scaffold KSR1 is Required for Recruitment of Extracellular Signal-Regulated Kinase to the Immunological Synapse 183
Physiological T cell activation starts and propagates in lipid rafts. 179
Vav1 controls DAP10-mediated natural cytotoxicity by regulating actin and microtubule dynamics. 179
Tumor-associated macrophages in Osteosarcoma: from mechanisms to therapy 178
Ligand-dependent activation of EGFR in follicular dendritic cells sarcoma is sustained by local production of cognate ligands. 177
A rare complex BRAF mutation involving codon V600 and K601 in primary cutaneous melanoma: Case Report. 171
Extracellular-regulated protein kinase 5-mediated control of p21 expression promotes macrophage proliferation associated with tumor growth and metastasis 170
Phosphatidylinositol 3-kinase activation is required to form the NKG2D immunological synapse. 168
Lipid rafts and T cell receptor signaling: a critical re-evaluation 165
Signaling and the immunological synapse 165
Dystrophin deficient myotubes undergo to apoptosis in mouse primary muscle cell culture after a DNA damage 163
Mesothelioma malignancy and the microenvironment: Molecular mechanisms 159
Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. 156
Role of scaffold molecules KSRs in cell migration and angiogenesis 151
The Balance between T Cell Receptor Signaling and Degradation at the Center of the Immunological Synapse Is Determined by Antigen Quality 150
The extracellular-regulated protein kinase 5 (ERK5) enhances metastatic burden in triple-negative breast cancer through focal adhesion protein kinase (FAK)-mediated regulation of cell adhesion. 148
CD96 (tactile) promotes NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155). 136
Clinical significance and regulation of ERK5 expression and function in cancer 131
Immuno-contexture and immune checkpoint molecule expression in microsatellite stable/mismatch repair proficient colorectal carcinoma 130
MEK5/ERK5 signaling mediates IL-4-induced M2 macrophage differentiation through regulation of c-Myc expression 124
Inhibition of FasL sustains phagocytic cells and dalays myogenesis in regenerating muscle fibers 116
null 108
Insights into CSF-1R Expression in the Tumor Microenvironment 104
Self-renewal of macrophages: tumor-released factors and signaling pathways 98
Inhibiting ERK5 overcomes breast cancer resistance to anti-HER2 therapy by targeting the G1/S cell cycle transition 91
Picomolar inhibition of plasmepsin V, an essential malaria protease, achieved exploiting the prime region 69
Progranulin and inflammation induced cancer: an important player in the tumor microenvironment? 13
Totale 7.813
Categoria #
all - tutte 25.583
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.583


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202160 0 0 0 0 0 0 0 0 0 0 0 60
2021/2022552 61 72 36 16 29 22 48 20 32 52 50 114
2022/2023701 41 47 86 79 59 143 69 48 78 7 23 21
2023/2024415 15 11 25 15 18 93 130 8 1 16 25 58
2024/20251.086 29 60 62 57 138 55 31 58 126 52 117 301
2025/20262.358 241 369 212 250 462 100 277 65 88 146 109 39
Totale 7.813